| Stereochemistry | ACHIRAL |
| Molecular Formula | C25H17FN2O2 |
| Molecular Weight | 396.4131 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CC=C(CN2C=C(C(=O)OC3=C4N=CC=CC4=CC=C3)C5=C2C=CC=C5)C=C1
InChI
InChIKey=ROHVURVXAOMRJY-UHFFFAOYSA-N
InChI=1S/C25H17FN2O2/c26-19-12-10-17(11-13-19)15-28-16-21(20-7-1-2-8-22(20)28)25(29)30-23-9-3-5-18-6-4-14-27-24(18)23/h1-14,16H,15H2
| Molecular Formula | C25H17FN2O2 |
| Molecular Weight | 396.4131 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 0.386 nM [Ki] | |||
| 0.478 nM [Ki] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|